Search for: "Mylan Inc."
Results 621 - 640
of 674
Sorted by Relevance
|
Sort by Date
11 Mar 2019, 7:08 pm
The Momenta Appeal At the time of its 2015 petition for inter partes review, Momenta was working with Mylan to develop a biosimilar counterpart to Orencia®, the branded biologic drug whose active ingredient was covered by the BMS patent. [read post]
15 Apr 2011, 6:02 am
Mylan Pharmaceuticals, Inc., 2009 WL 7115134, at *2 (N.D. [read post]
31 Mar 2010, 1:58 pm
Prods., Inc. v. [read post]
28 Aug 2013, 10:31 am
By Dennis Crouch Leo Pharmaceutical Products, Ltd. v. [read post]
2 Feb 2012, 8:53 pm
Bard, Inc. [read post]
26 Jan 2015, 4:03 am
.* JUST OUT - Molecular weights at the Supreme Court - Teva v SandozThe IPKat has already covered the UK litigation of Generics (t/a Mylan) v Yeda/Teva, in which a patent that covered glatiramer acetate was held valid even though the claims specified a particular molecular weight range without specifying what method was used to measure that weight (here, here, and here). [read post]
31 Jan 2014, 7:26 am
Mylan, Inc., No. 12-2502, 2013 U.S. [read post]
1 Oct 2009, 2:14 am
Mylan Pharmaceuticals, 2008 WL 3540462 (N.D.W. [read post]
7 May 2010, 11:11 am
See Genentech, Inc. v. [read post]
14 Mar 2011, 8:12 pm
(forthcoming)Motion for leave to file out of time amicus brief of American Bankers AssociationPetitioner's reply Title: Mylan Inc. v. [read post]
30 Apr 2007, 10:51 am
Mylan Labs, Inc., 464 F.3d 1286, 1291 (2006)), even if the advantage was not one that the inventor contemplated or that the patent itself disclosed. [read post]
30 Apr 2007, 4:50 pm
Mylan Labs, Inc., 464 F.3d 1286, 1291 (2006)), even if the advantage was not one that the inventor contemplated or that the patent itself disclosed. [read post]
3 Feb 2011, 2:11 pm
Mylan Pharmaceuticals., Inc., 696 F. [read post]
23 Dec 2007, 8:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at [feeds.feedburner.com]GlobalEvents in Bali heap further pressure on all IP owners: (IAM),Velcro defies generic claim in domain name battle: (OUT-LAW),ICANN forms group to hasten non-English domain names: (IP Justice)WTO members continue debate on geographical indications register: (Intellectual Property Watch),Creative Commons launches CCo and CC programs: (World IP Day),Green IP Strategy - risks… [read post]
22 Feb 2008, 6:00 pm
Signature Financial Group, Inc., and AT&T Corp. v. [read post]
28 Jun 2007, 10:16 am
Pfizer, Inc., ___ F. [read post]
8 Sep 2011, 12:59 pm
., a maker and distributor of generic drugs, engaged in an illegal drug- switching scheme to increase sales, the U.S. said in a lawsuit in which two Mylan Inc. units are also accused by a whistleblower of wrongdoing. [read post]
18 Aug 2022, 4:43 am
Suzanne prosecuted many notable FCA cases in the government, including several qui tam cases against National Medicare Care, Inc. [read post]
9 Apr 2009, 7:52 am
(IP Think Tank) Brazilian public-private partnerships in the pharma industry (IP tango) EU: ECJ to rule on reference on SPC Regulation interpretation from Lithuania in Kirin Amgen, Inc. v Lietuvos Respublikos valstybinis patentų biuras (The SPC Blog) India: Delhi High Court Dasatinib order: Is patent-drug regulatory linkage a necessity? [read post]
15 Jul 2009, 5:15 am
IPAB rejects Novartis’ patent application for Glivec (Intellectual Property Watch) Lescol (Fluvastatin) – Netherlands: No interim relief pending appeal against invalidity, rules District Court of The Hague: Novartis v Mylan and Actavis (PatLit) Levaquin (Levoflaxacin) – Canada: FCA holds generics raising allegations similar to those of previous generics allowed their day in court: Apotex v Janssen-Ortho (Global IP Watch) Lexapro (Escitalopram) – US:… [read post]
